Convergence Investment Partners, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1456133
PALM BEACH GARDENS, FL
Position in NBIX
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$5,466,257
New position
Shares Held
32,433
first reported quarter
Ownership
0.032%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#204
of 774 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Convergence Investment Partners, LLC holds $12,621,502 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (43.3% of the industry book) .
All Filings in NBIX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,466,257 | 32,433 | Shares | Sole | 2026-07-31 | |
| No filing history on record for this holder in this stock. | ||||||